A Study to Evaluate Treatment Patterns and Effectiveness of Luspatercept (clinicaltrials.gov) - Oct 1, 2026 - P=N/A | N=430 | Completed | Sponsor: Bristol-Myers Squibb | Active, not recruiting ➔ Completed
Real-world evidence • Trial completion • Hematological Malignancies • Myelodysplastic Syndrome • Oncology
|